 SILVER SPRING, Md., Jan. 24, 2023 PRNewswire Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA issued a final guidance Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research, Guidance for Industry. This guidance provides the FDAs current thinking on several ...... 